Annual Meeting Home Past & Future Meetings

Back to Annual Meeting Program

Epidemiology and Outcomes of C. difficile Infections in the Elderly
*Courtney Collins, *M. Didem Ayturk, *Julie M Flahive, Timothy A Emhoff, *Fred A. Anderson, Jr, *Heena P. Santry
University of Massachusetts, Worcester, MA

To examine the epidemiology and outcomes of Medicare beneficiaries admitted with community acquired C. difficile infections.
Retrospective review of national administrative database(Medicare)
5% random sample of Medicare claims data (2009-2010) including inpatient, outpatient, and Part D (outpatient prescription drug claims) data.
Patients or Other Participants
C.difficile cases were defined as any hospital admission with a primary ICD-9 diagnosis code=08.45. Cases were limited to community-acquired C.difficile (CACD) infections by including only the first C.difficile admission and excluding patients hospitalized OR receiving IV/IM antibiotics in the 90 days prior to admission.
Main Outcome Measures
We determined the rate of CACD, patient characteristics (age, co-morbidities, sex, race), pre-admission antibiotic exposure (<30 days, 31-60 days, 61-90 days) and C.difficile treatment, inpatient outcomes (colectomy, ICU stay, length of stay, mortality), and subsequent admissions for C.difficile.
2049 (0.25%) patients were admitted with C. difficile, 1061 (52%) with CACD. 50% of CACD patients received oral antibiotics within 90 days of admission: <31dys=39%, 31-60dys=8%, and 61- 90dys=3.7%. Few were treated pre-admission with oral Metronidazole (4.5%) or Vancomycin (0.7%).13% of patients required ICU admission with a median ICU-LOS of 4 (IQR 6). Few(1.3%) underwent colectomy. Hospital mortality was 10.8%. Median overall LOS was 5 days (IQR 5). 20% of survivors were re-admitted with C.difficile within one year of discharge.
Half of Medicare beneficiaries admitted with CACD have no recent antibiotic exposure. High mortality and re-admission rates suggest that the burden of C.difficile on patients and the healthcare system will be significant as the US population ages if the virulence of CACD continues to increase.

Back to Annual Meeting Program


Abstract Submission Deadline:
May 5, 2014

Housing Deadline:
August 13, 2014

Early Bird Registration Deadline:
August 11, 2014
© 2020 New England Surgical Society. All Rights Reserved. Privacy Policy.